Abstract:Patients with myocardial ischemia and infarction are at increased risk of arrhythmias, which in turn, can exacerbate the overall risk of mortality. Despite the observed reduction in recurrent arrhythmias through antiarrhythmic drug therapy, the precise mechanisms underlying their effectiveness in treating ischemic heart disease remain unclear. Moreover, there is a lack of specialized drugs designed explicitly for the treatment of myocardial ischemic arrhythmia. This study employs an electrophysiological simulation approach to investigate the potential antiarrhythmic effects and underlying mechanisms of various pharmacological agents in the context of ischemia and myocardial infarction (MI). Based on physiological experimental data, computational models are developed to simulate the effects of a series of pharmacological agents (amiodarone, telmisartan, E-4031, chromanol 293B, and glibenclamide) on cellular electrophysiology and utilized to further evaluate their antiarrhythmic effectiveness during ischemia. On 2D and 3D tissues with multiple pathological conditions, the simulation results indicate that the antiarrhythmic effect of glibenclamide is primarily attributed to the suppression of efflux of potassium ion to facilitate the restitution of [K + ] o , as opposed to recovery of I KATP during myocardial ischemia. This discovery implies that, during acute cardiac ischemia, pro-arrhythmogenic alterations in cardiac tissue's excitability and conduction properties are more significantly influenced by electrophysiological changes in the depolarization rate, as opposed to variations in the action potential duration (APD). These findings offer specific insights into potentially effective targets for investigating ischemic arrhythmias, providing significant guidance for clinical interventions in acute coronary syndrome. In acute coronary syndrome, the progression of ischemic, injury, and infarction conditions heightens the risk of ischemic cardiac arrhythmias. Despite the existence of various antiarrhythmic drugs, there remains a scarcity of medications specifically tailored for ischemic cardiac arrhythmias. Moreover, comprehending the diverse drug responses in tissues with multiple ischemic conditions (ischemia 1a, 1b, and infarction) remains incomplete. Therefore, in this study, mathematical models depicting the electrophysiological remodeling induced by different drugs such as amiodarone, telmisartan, E-4031, chromanol 293B, and glibenclamide, are constructed and integrated into multi-scale computational models to assess their antiarrhythmic effects. Simulation results demonstrate the potential of glibenclamide in mitigating ischemic cardiac arrhythmias. It can be attributed to its ability not only to improve the depolarization phase's membrane potential by inhibiting extracellular potassium accumulation during the ischemic stage, leading to an increased dV/dt max , but also to extend the action potential duration (APD) by suppressing I KATP . Finally, the application of glibenclamide results in heightened conduction velocity and prolonged APD at the tissue level. Consequently, these effects enlarge the wavelength of excitation waves, ultimately reducing the vulnerable window for reentrant wave and exhibiting an anti-ischemic arrhythmic effect. More importantly, it's shown that glibenclamide's inhibition of [K + ] o yields a more significant impact on antiarrhythmic effects compared to its prolongation of APD. This is partly due to the more pronounced enhancement in the wavelength of excitation waves resulting from CV elevation compared with APD prolongation. Additionally, in tissues with coexisting multiple ischemic conditions, suppressing [K + ] o reduces the spatial dispersion of CV, especially at the boundaries of different ischemic tissues like ischemia 1b and infarction, facilitating a more uniform excitation wave propagation. This study offers insights into the anti-arrhythmic mechanisms of established agents during acute coronary syndrome and identifies potential targets for novel anti-arrhythmic drug development.

Inhibition of Late Sodium Current: A Novel Target to Treat Cardiac Arrhythmias

Inhibition of Late Sodium Current Suppresses Calcium-Related Ventricular Arrhythmias by Reducing the Phosphorylation of CaMK-II and Sodium Channel Expressions

Late sodium current associated cardiac electrophysiological and mechanical dysfunction

BISOPROLOL INHIBITS SODIUM CURRENT IN VENTRICULAR MYOCYTES OF RATS WITH DIASTOLIC HEART FAILURE

Modulating the voltage sensor of a cardiac potassium channel shows antiarrhythmic effects

1,4-Disubstituted Piperazin-2-Ones As Selective Late Sodium Current Inhibitors with QT Interval Shortening Properties in Isolated Rabbit Hearts.

Effects of inhibition of endogenous late sodium current on the reverse rate dependence and transmural dispersion of action potential duration prolongation by drugs that inhibit potassium currents

Abstract 14727: Late Sodium Current Plays a Role in Ventricular Arrhythmias Associated with Increased Intracellular Calcium Concentration

Proarrhythmic Potential of Low-risk Drugs That Affect the Ventricular Repolarization

Proarrhythmic and Antiarrhythmic Effects of Multiple Ion Channel Inhibitors Modulated by the Late Sodium Current

Late Sodium Current in Atrial Cardiomyocytes Contributes to the Induced and Spontaneous Atrial Fibrillation in Rabbit Hearts

Effects of the Late Sodium Current Inhibitor on the Interatrial Conduction Time and Acetylcholine-Induced Atrial Fibrillation

Theoretical possibilities for the development of novel antiarrhythmic drugs

Natural products as the calcium channel blockers for the treatment of arrhythmia: Advance and prospect

Cardiac arrhythmogenesis: roles of ion channels and their functional modification

Novel ion channel targets in atrial fibrillation

Late Sodium Current in Synergism with Ca2+/calmodulin-dependent Protein Kinase II Contributes to Β-Adrenergic Activation-Induced Atrial Fibrillation.

ASSA14-03-46 Inhibition of Late Sodium Current Reduces the Reverse Rate Dependence of Action Potential Duration Prolongation Induced by L-type Calcium Channel Activator

Differential regulation of sodium channels as a novel proarrhythmic mechanism in the human failing heart

Inhibition of late sodium current via PI3K/Akt signaling prevents cellular remodeling in tachypacing-induced HL-1 atrial myocytes

A simulation study on the antiarrhythmic mechanisms of established agents in myocardial ischemia and infarction